In 2023, HarveyCEO initiated the partnership between an accomplished life sciences executive and a Nashville-based private equity firm to pursue an investment thesis that the executive developed around the biochemicals, life science consumables, and specialty reagents industry. The partnership resulted in the formation of VION Biosciences through the acquisition of Aldon Corporation. The executive now serves as the holding company CEO and is spearheading the strategy to grow the business both commercially and in-organically through its new phase of private equity ownership. VION is positioned to become a leading life science company providing both manufacturing and mission-critical chemicals and specialty reagents alongside value-added services, which enable scientific discovery, clinical testing, therapeutic development, and innovative solutions across a wide platform of key applications from research to commercialization.